Prescriber Certification Workflow
Prescriber certification manages training, knowledge assessment, and attestation, tracking status in the way credentialing systems handle professional verification.
Custom Software
Pharma REMS Platform Development
REMS platforms enforce FDA-required Risk Evaluation and Mitigation Strategy elements including prescriber certification, pharmacy certification, patient enrollment, and monitoring requirements. Because dispensing depends on these checks, the platform sits directly in the path between a prescription and a patient receiving therapy, which sets the reliability bar.
A REMS platform is unusual among pharma systems: if it fails, patients do not get medication. That makes availability and usability safety concerns rather than service quality metrics, and it explains why several REMS programs have drawn criticism for creating access barriers. Taction Software builds pharma REMS platform capability with that burden explicitly managed.
Tell Us Your Requirements
Our experts are ready to understand your business goals.
Trusted Partners
Trusted by Industry Leaders Worldwide
Recognition
Awards & Recognitions
What Is a REMS Platform
A pharma REMS platform implements the FDA-approved risk management requirements for a drug, typically including some combination of prescriber certification, pharmacy or healthcare setting certification, patient enrollment and agreement, laboratory monitoring verification, and documented safe use conditions known as ETASU. The platform verifies these before dispensing and produces the assessment reporting FDA requires. Our work sits within our broader pharma and life sciences practice.
Pharmacy and Setting Certification
Pharmacy certification verifies dispensing locations meet program requirements, since REMS drugs may only be dispensed through certified channels.
Patient Enrollment and Agreement
Patient enrollment captures counseling documentation and agreements, with accessibility treated as a safety requirement rather than a design preference.
ETASU Verification
ETASU checks verify all required elements before dispensing authorization, since this verification is what the REMS actually exists to enforce.
Monitoring and Laboratory Verification
Where programs require testing, monitoring verification confirms results before authorization, integrating with laboratory and prescriber-supplied data.
Assessment and FDA Reporting
REMS assessment reports are produced from program data on the schedule FDA requires, supported by complete audit records of every verification.
Core REMS Platform Services
Our REMS platform services cover certification workflow, enrollment systems, dispensing authorization, integration, and assessment reporting. The design constraint that shapes everything is that friction in a REMS platform translates directly into patients not receiving therapy. FDA has emphasized minimizing burden while maintaining safety, and several programs have been publicly criticized for the opposite. We treat usability as a program safety requirement. Engagements typically open with a review of the approved REMS document and its specific requirements.
01
Certification Management
We build certification workflow for prescribers and pharmacies, drawing on our credentialing automation work for verification tracking patterns.
02
Enrollment and Consent Systems
Enrollment tooling captures required documentation with accessible interfaces, since enrollment friction directly delays therapy for patients who qualify.
03
Dispensing Authorization
Authorization checks verify ETASU status at dispensing, integrating with pharmacy systems through our Surescripts integration work where applicable.
04
Patient-Facing Access
Patient interfaces draw on our patient engagement app development practice, prioritizing accessibility across literacy and device constraints.
05
Registry and Monitoring Data
Where programs include registries, our clinical registry software development work covers longitudinal data capture and quality.
06
Part 11 Validated Delivery
REMS systems support regulatory obligations. Our 21 CFR Part 11 for AI work covers validation and audit trail requirements.
Benefits of a Purpose-Built REMS Platform
The benefits concentrate in reliable ETASU enforcement, reduced access friction, and defensible assessment reporting. REMS programs frequently run on systems that satisfy FDA requirements while frustrating the prescribers and pharmacists who must use them, which produces workarounds, complaints, and access delays. We publish no figures on enrollment rates, dispensing turnaround, or program performance, because those depend entirely on program design and the drug’s clinical context.
Reliable Requirement Enforcement
Systematic ETASU verification ensures requirements are checked consistently rather than depending on manual confirmation under dispensing pressure.
Reduced Access Friction
Usable enrollment and certification workflow reduces the delay between prescription and dispensing, which is where REMS programs most commonly fail patients.
Defensible Assessment Reporting
Complete audit records support FDA assessment reporting with evidence rather than reconstructed summaries assembled before each submission.
Clearer Stakeholder Visibility
Status visibility for prescribers and pharmacists reduces support call volume from participants who cannot determine why an authorization failed.
Supported Program Modification
Structured program data supports REMS modification submissions, where demonstrating burden or effectiveness requires real operational evidence.
Shared System Coordination
For shared system REMS covering multiple sponsors, the platform coordinates certification across products without duplicating participant effort.
Our REMS Platform Process
We deliver REMS platform projects in gated phases so regulatory, safety, and commercial stakeholders approve direction before engineering cost accumulates. Discovery begins with the approved REMS document itself, since the software must implement exactly what FDA approved rather than a reasonable interpretation of it. Usability testing with prescribers and pharmacists is a required phase, not an optional refinement, because access friction in this category has real clinical consequence.
Discovery and REMS Document Review
Discovery works from the approved REMS, implementing exactly what FDA approved rather than an interpretation, since deviation creates compliance exposure.
Requirement Mapping
We map each ETASU element to system verification, producing traceability from regulatory requirement through implementation to test evidence.
Usability Testing With Participants
Usability testing with prescribers and pharmacists is required, since friction translates directly into patients not receiving prescribed therapy.
Integration Development
Integration spans pharmacy systems, laboratories, and certification data sources, each with different availability and interface quality.
Validation and Testing
Computer system validation produces documented evidence, with particular attention to authorization logic where errors block legitimate dispensing.
Launch and Ongoing Support
Launch includes participant support tooling and monitoring, with continuing support as the REMS is modified or requirements change.
Technology and Compliance
REMS platforms operate under the approved REMS document, 21 CFR Part 11 for records supporting regulatory obligations, and HIPAA where patient data is handled under authorization. Taction holds ISO 27001 certification. Two requirements deserve emphasis. The platform must implement the approved REMS precisely, since deviating creates compliance exposure regardless of whether the deviation seems reasonable. And availability is a safety matter: an outage means patients cannot receive medication, which is a different severity class than commercial system downtime.
Approved REMS Fidelity
The system implements the approved REMS exactly. Improvements require FDA modification rather than unilateral changes to how requirements are enforced.
21 CFR Part 11 Compliance
Part 11 governs records supporting regulatory obligations, requiring audit trails, electronic signatures, and computer system validation.
Availability as Safety
System availability is a patient safety requirement, since an outage blocks dispensing. Redundancy and recovery objectives are set accordingly.
Patient Data Handling
Patient enrollment data is handled under authorization with HIPAA-aligned controls. Our HIPAA compliance practice defines them.
Access Burden Monitoring
Burden monitoring tracks where participants abandon certification or enrollment, supporting modification submissions with operational evidence.
Deployment Security
Deployments run in your cloud tenancy or hybrid, with network segmentation, signed container images, and documented penetration testing before release.
Why Choose Taction Software
Taction Software was founded in 2013 and has spent over 12 years building healthcare and life sciences software, delivering more than 200 healthcare projects from four US offices in Chicago, Cheyenne, Austin, and Sacramento, with ISO 27001 certification. Our relevant position here is treating usability as a safety requirement. REMS programs that satisfy FDA while frustrating participants produce access delays that harm patients, and that outcome is a design failure rather than an acceptable tradeoff. Our leadership brings more than 20 years of personal experience in the field.
01
Usability as Safety
We treat access friction as a patient safety issue, since REMS burden translates directly into prescribed therapy not reaching patients.
02
Verification Workflow Experience
Our credentialing and verification work covers the professional certification patterns REMS prescriber and pharmacy enrollment requires.
03
Established Healthcare Focus
Founded in 2013, we have concentrated on healthcare and life sciences rather than treating them as one vertical among several.
04
Patient-Facing Delivery
We have shipped FDA-registered patient applications including Revive Ease and PainKare, so patient usability in regulated contexts is established practice.
05
Validated System Delivery
We build Part 11 audit trails and validation documentation from the start, since REMS records support ongoing regulatory obligations.
06
Certified Security Posture
ISO 27001 certification means security controls are documented and auditable, supporting sponsor vendor qualification efficiently.
Pricing
REMS platform pricing depends on the approved requirements, participant volume, integration scope, and validation depth. Programs with laboratory verification, time-limited authorization windows, or long-term follow-up carry substantially more complexity than education and attestation programs. Discovery produces an itemized, fixed-scope estimate with phase-level breakdown after reviewing the approved REMS document. Cloud infrastructure, call center services, and integration vendor fees are separate from engineering cost and itemized clearly.
MVP or Single Module
An MVP covering prescriber certification and attestation typically runs $40,000 to $80,000 for programs with straightforward requirements.
Full Platform Build
A full platform with certification, enrollment, dispensing authorization, and assessment reporting typically falls between $80,000 and $200,000.
Enterprise Deployment
Enterprise engagements covering shared system REMS, laboratory integration, and long-term registry follow-up start at $200,000.
Discovery Phase Scoping
Discovery is a paid, time-boxed phase producing an itemized estimate, requirement traceability map, and validation scope assessment.
Cost Drivers to Expect
ETASU complexity, laboratory verification, participant volume, and shared system coordination are the largest variables, identified during discovery.
Ongoing Support Costs
Post-launch participant support, REMS modification changes, assessment reporting, and availability management are quoted separately as a retainer.
Get Started
If you are evaluating a REMS platform for prescriber certification, patient enrollment, dispensing authorization, or assessment reporting, the fastest next step is a discovery call with our team. We will review your approved REMS document, map requirements to system verification, and return an itemized, fixed-scope estimate. Contact us to schedule that conversation.
FAQs
Frequently Asked Questions
Regulatory and program leaders evaluating REMS platform development usually ask about implementation fidelity, access burden, and availability requirements. The answers below reflect how we scope these projects. If your REMS includes laboratory verification or time-limited authorization windows, those elements drive complexity more than participant volume does.
Not unilaterally. The system implements what FDA approved, and changes to how requirements are enforced need a REMS modification submission. We can build burden monitoring that produces the operational evidence a modification submission requires, but the platform must implement the current approved program faithfully.
Through usability testing with actual prescribers and pharmacists, accessible patient enrollment, and clear status visibility so participants understand why an authorization failed. Burden reduction within the approved requirements is a design problem, and we treat it as a safety objective rather than a satisfaction metric.
Higher than typical commercial systems, because an outage means patients cannot receive medication. We set redundancy and recovery objectives accordingly and document them explicitly, since availability in this context is a patient safety property rather than a service level preference.
An MVP covering certification runs $40,000 to $80,000. A full platform typically falls between $80,000 and $200,000. Enterprise shared system deployments with laboratory integration start at $200,000. The approved REMS requirements drive cost more than participant volume.
Yes, including coordinated certification across sponsors so prescribers and pharmacies enroll once rather than repeatedly per product. Shared systems add coordination complexity and governance requirements between sponsors, which we scope explicitly during discovery.
Yes, and this matters. REMS populations frequently include patients without reliable device or internet access, so enrollment paths must accommodate phone and paper-assisted routes. Digital-only enrollment creates access barriers for exactly the patients least able to overcome them.